May 12, 2020 – Annals of Internal Medicine Richard E. Gliklich, MD; Michelle B. Leavy, MPH; Lisa Cosgrove, PhD; Gregory E. Simon, MD, MPH; Bradley N. Gaynes, MD, MPH; Lars E. Peterson, MD, PhD; Bryan Olin, PhD; Collette Cole, RN, BSN; J. Raymond DePaulo Jr., MD; Philip Wang, MD, DrPH; Chris M. Crowe, PhD; Cristina[…]
New Project Puts Standardized Outcomes Measures for Depression into Real-World Use, from Registries to the Clinic OM1 partners with AHRQ, ABFM, APA and others to implement BOSTON, July 17, 2019 —OM1, a leading health outcomes and technology company, today announced it is has been awarded the CAPSTONE – Outcome Measure Harmonization and Data Infrastructure for[…]
Read the decision memo: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=292
November 15, 2018 —OM1, a leading health outcomes and technology company, today announced the publication of new harmonized outcome measures for atrial fibrillation (AF) in HeartRhythm. OM1’s Richard Gliklich and Michelle Leavy collaborated on the development of the measures and co-authored the publication. The work was funded by the Agency for Healthcare Research and Quality (AHRQ) through[…]
by Joyce Frieden, News Editor, MedPage Today, April 28, 2017 WASHINGTON — Measuring outcomes for heart disease treatment in the general population won’t do much good if researchers can’t agree on a single definition of a particular disease or on which outcomes are worth measuring. That’s why a group of interested organizations is developing a common[…]
